D
Bausch + Lomb Corporation BLCO.TO
TSX
Recommendation
Prev Close
$15.99
Volume
--
Avg Vol (90D)
3,498
Market Cap
$4.06B
Dividend & Yield
--
52-Week Range
$14.56 - $29.37
P/E (TTM)
--
EPS (TTM)
-$1.03
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb ...
5/9/2025 - GuruFocus
Diameter Capital Partners LP Reduces Stock Position in Bausch + Lomb Co. (NYSE:BLCO)
5/9/2025 - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
5/9/2025 - Globe Newswire
25,674 Shares in Bausch + Lomb Co. (NYSE:BLCO) Purchased by Caption Management LLC
5/9/2025 - MarketBeat
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced -- Investors Who ...
5/8/2025 - GuruFocus
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
5/8/2025 - Business Wire
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money -- Contact Law Offices of Howard G. ...
5/8/2025 - GuruFocus
Bausch + Lomb Corporation (BLCO) Investors Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
5/8/2025 - Business Wire
Morgan Stanley Issues Pessimistic Forecast for Bausch + Lomb (NYSE:BLCO) Stock Price
5/8/2025 - MarketBeat
3 Profitable Stocks Walking a Fine Line
5/8/2025 - StockStory Articles
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced -- Investors Who ...
5/8/2025 - GuruFocus
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Announced Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
5/8/2025 - Business Wire
Bausch + Lomb's LuxLife Intraocular Lens Gains European CE Mark Approval
5/7/2025 - TipRanks Financial Blog
Bausch + Lomb gets European nod for intraocular lens
5/7/2025 - Seeking Alpha - Healthcare
Bausch + Lomb (BLCO) Receives CE Mark for LuxLife Intraocular Lens BLCO Stock News
5/7/2025 - GuruFocus
bausch lomb receives european ce mark approval for preloaded luxlife full range of vision intraocular lens
5/7/2025 - GuruFocus
Bausch + Lomb announces CE Mark approval for LuxLife
5/7/2025 - The Fly
Brevan Howard Capital Management LP Purchases New Shares in Bausch + Lomb Co. (NYSE:BLCO)
5/7/2025 - MarketBeat
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife Full Range of Vision Intraocular Lens
5/7/2025 - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb ...
5/6/2025 - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
5/6/2025 - PR Newswire
Bausch & Lomb (BLCO) Price Target Lowered by Morgan Stanley BLCO Stock News
5/6/2025 - GuruFocus
Morgan Stanley Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $12.00
5/6/2025 - Ticker Report
Bausch + Lomb First Quarter 2025 Earnings: Misses Expectations
5/6/2025 - Simply Wall St
Price T Rowe Associates Inc. MD Acquires New Holdings in Bausch + Lomb Co. (NYSE:BLCO)
5/5/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$4.83B
EBITDA (TTM)
$559.00M
EBIT (TTM)
$127.00M
Net Income (TTM)
-$362.00M
Balance Sheet
Total Assets (Q)
$13.43B
Total Debt (Q)
$4.83B
Total Liabilities (Q)
$7.00B
Book Value Per Share (Q)
$18.00
Cash Flow
Cash from Operations (TTM)
$166.00M
Cash from Investing (TTM)
-$471.00M
Cash from Financing (TTM)
$197.00M
Net Change in Cash (TTM)
-$110.00M
Filings
Filing Date
Wednesday, April 30, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Loading...
Beta
0.79
7-Day Total Return
4.85%
30-Day Total Return
-25.38%
60-Day Total Return
-32.04%
90-Day Total Return
-38.41%
Year to Date Total Return
-38.38%
1-Year Total Return
-23.01%
2-Year Total Return
-35.26%
3-Year Total Return
-31.40%
5-Year Total Return
--
52-week Low
Apr 30, 2025 - $14.56
52-week High
Oct 15, 2024 - $29.37
Valuation
Market Cap
$4.06B - Mid Cap
Enterprise Value
$8.76B
Price/Sales (TTM)
1.17
Price/Book (Q)
0.89
Dividends and Shares
Shares Outstanding
352.80M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bausch.com
Phone Number
905-695-7700
Address
520 Applewood Crescent
Vaughan, ON L4K 4B4
Country
Canada
Year Founded
1853
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and... more